Cargando…

Safety of BNT162b2 mRNA vaccine booster in the setting of Ad26.COV2.S-associated VITT

Detalles Bibliográficos
Autores principales: Abou-Ismail, Mouhamed Yazan, Kanack, Adam J., Splinter, Noah P., Smock, Kristi J., Moser, Karen A., Padmanabhan, Anand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631692/
https://www.ncbi.nlm.nih.gov/pubmed/35468623
http://dx.doi.org/10.1182/bloodadvances.2022007753
_version_ 1784823870204674048
author Abou-Ismail, Mouhamed Yazan
Kanack, Adam J.
Splinter, Noah P.
Smock, Kristi J.
Moser, Karen A.
Padmanabhan, Anand
author_facet Abou-Ismail, Mouhamed Yazan
Kanack, Adam J.
Splinter, Noah P.
Smock, Kristi J.
Moser, Karen A.
Padmanabhan, Anand
author_sort Abou-Ismail, Mouhamed Yazan
collection PubMed
description
format Online
Article
Text
id pubmed-9631692
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-96316922022-11-04 Safety of BNT162b2 mRNA vaccine booster in the setting of Ad26.COV2.S-associated VITT Abou-Ismail, Mouhamed Yazan Kanack, Adam J. Splinter, Noah P. Smock, Kristi J. Moser, Karen A. Padmanabhan, Anand Blood Adv Research Letter American Society of Hematology 2022-09-20 /pmc/articles/PMC9631692/ /pubmed/35468623 http://dx.doi.org/10.1182/bloodadvances.2022007753 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://www.ncbi.nlm.nih.gov/pmc/pmcdoc/tagging-guidelines/article/tags.html#el-licenseThis article is made available via the PMC Open Access Subset for unrestricted reuse and analyses in any form or by any means with acknowledgment of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
spellingShingle Research Letter
Abou-Ismail, Mouhamed Yazan
Kanack, Adam J.
Splinter, Noah P.
Smock, Kristi J.
Moser, Karen A.
Padmanabhan, Anand
Safety of BNT162b2 mRNA vaccine booster in the setting of Ad26.COV2.S-associated VITT
title Safety of BNT162b2 mRNA vaccine booster in the setting of Ad26.COV2.S-associated VITT
title_full Safety of BNT162b2 mRNA vaccine booster in the setting of Ad26.COV2.S-associated VITT
title_fullStr Safety of BNT162b2 mRNA vaccine booster in the setting of Ad26.COV2.S-associated VITT
title_full_unstemmed Safety of BNT162b2 mRNA vaccine booster in the setting of Ad26.COV2.S-associated VITT
title_short Safety of BNT162b2 mRNA vaccine booster in the setting of Ad26.COV2.S-associated VITT
title_sort safety of bnt162b2 mrna vaccine booster in the setting of ad26.cov2.s-associated vitt
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631692/
https://www.ncbi.nlm.nih.gov/pubmed/35468623
http://dx.doi.org/10.1182/bloodadvances.2022007753
work_keys_str_mv AT abouismailmouhamedyazan safetyofbnt162b2mrnavaccineboosterinthesettingofad26cov2sassociatedvitt
AT kanackadamj safetyofbnt162b2mrnavaccineboosterinthesettingofad26cov2sassociatedvitt
AT splinternoahp safetyofbnt162b2mrnavaccineboosterinthesettingofad26cov2sassociatedvitt
AT smockkristij safetyofbnt162b2mrnavaccineboosterinthesettingofad26cov2sassociatedvitt
AT moserkarena safetyofbnt162b2mrnavaccineboosterinthesettingofad26cov2sassociatedvitt
AT padmanabhananand safetyofbnt162b2mrnavaccineboosterinthesettingofad26cov2sassociatedvitt